Remibrutinib Improves Chronic Spontaneous Urticaria in Patients Irrespective of Previous Anti-IgE Treatment: Results From a Phase 2b Study

被引：0
|
作者：
Greiner, Alexander [1 ,2 ]
Guduri, Sridhar [3 ]
Leflein, Jeffrey [4 ]
Haemmerle, Sibylle [5 ]
Lheritier, Karine [5 ]
Walsh, Pauline [6 ]
Nikolaev, Ivan [5 ]
Gimenez-Arnau, Ana [7 ]
Maurer, Marcus [8 ]
机构：
[1] Allergy & Asthma Med Grp & Res Ctr, San Diego, CA USA
[2] Univ Calif San Diego, San Diego, CA USA
[3] Centricity Res Inc, Columbus, OH USA
[4] Resp Med Res Inst Michigan, Ann Arbor, MI USA
[5] Novartis Pharma AG, Basel, Switzerland
[6] Novartis Ireland Ltd, Dublin, Ireland
[7] Univ Pompeu Fabra, Hosp Mar IMIM, Barcelona, Spain
[8] Charit Univ Med Berlin, Urticaria Ctr Reference & Excellence UCARE, Berlin, Germany
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2023年 / 151卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
404
引用
收藏
页码：AB131 / AB131
页数：1
相关论文
共 50 条
  • [21] EFFICACY OF ANTI-IGE MONOCLONAL ANTIBODIES AT A DOSE OF 150 TO 300MG IN PATIENTS WITH CHRONIC URTICARIA SPONTANEOUS (CUS) WITH FAILURE IN THE EFFICACY OF ANTIHISTAMINE
    Rojo-Gutierrez, M. I.
    Flores Ruvalcaba, C. N.
    Mellado Abrego, J.
    Castillo Narvaez, G.
    Gonzalez Ibarra, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A113 - A113
  • [22] High rate of complete response achieved with ligelizumab in patients with moderate to severe chronic spontaneous urticaria throughout the phase 2b core study
    Bernstein, Jonathan A.
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Soong, Weily
    Sitz, Karl
    Hua, Eva
    Barbier, Nathalie
    Barve, Avantika
    Severin, Thomas
    Janocha, Reinhold
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB137 - AB137
  • [23] Dupilumab Improves Itch And Urticaria Activity In Patients With Chronic Spontaneous Urticaria: Pooled Results From Two Phase 3 Trials (LIBERTY-CSU CUPID Study A and Study C)
    Casale, Thomas
    Saini, Sarbjit
    Bernstein, Jonathan
    Gimenez-Arnau, Ana Maria
    Hayama, Koremasa
    Bauer, Deborah
    Amin, Nikhil
    Robinson, Lacey
    Dakin, Paula
    Laws, Elizabeth
    Radin, Allen
    Makhija, Melanie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB428 - AB428
  • [24] EFFICACY OF OMALIZUMAB, AN ANTI-IGE RECOMBINANT, HUMANIZED, MONOCLONAL ANTIBODY, FOR THE TREATMENT OF SEVERE CHRONIC IDIOPATHIC URTICARIA PATIENTS NOT CONTROLLED ON ORAL ANTIHISTAMINES
    Nsouli, S. M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A117 - A117
  • [25] Efficacy and Safety of Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 DoseRanging Study
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ferrucci, Silvia
    Mikol, Vincent
    Sun, Iris
    Mannent, Leda
    Gereige, Jessica
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB373 - AB373
  • [26] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MONOCLONAL ANTI-IGE ANTIBODY OMALIZUMAB IN THE MANAGEMENT OF PRURITUS IN CHRONIC SPONTANEOUS URTICARIA IN THE PEDIATRIC POPULATION
    Mitra, Barnali
    Vasudevan, Biju
    Solanki, Reema
    Mitra, Debdeep
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 1016 - 1017
  • [27] A randomized, double-blind, placebo-controlled study of monoclonal Anti-IgE antibody Omalizumab in the management of pruritus in chronic spontaneous urticaria in the pediatric population
    Mitra, B.
    EXPERIMENTAL DERMATOLOGY, 2018, 27 : 5 - 5
  • [28] Time to Onset of Linaclotide Effect On the Bowel Habits in Patients with Chronic Constipation: Results from a Phase 2B Study
    Johnston, Jeffrey M.
    Lavins, Bernard J.
    MacDougall, James E.
    Lembo, Anthony J.
    Schneier, Harvey
    Shiff, Steven J.
    Kurtz, Caroline B.
    Currie, Mark G.
    GASTROENTEROLOGY, 2009, 136 (05) : A537 - A537
  • [29] Efficacy of Remibrutinib in Patients With Chronic Spontaneous Urticaria With or Without Prior Exposure to Biologics in the Phase 3 REMIX-1 and REMIX-2 Studies
    Mosnaim, Giselle
    Gimenez-Arnau, Ana
    Hide, Michihiro
    Lebwohl, Mark
    Maurer, Marcus
    Metz, Martin
    Saini, Sarbjit
    Sussman, Gordon
    Haemmerle, Sibylle
    Lheritier, Karine
    Martzloff, El-Djouher
    Seko, Noriko
    Wang, Pengpeng
    Gogate, Shalia
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB369 - AB369
  • [30] Differentiation between control subjects and patients with chronic spontaneous urticaria based on the ability of anti-IgE autoantibodies to induce FcεRI crosslinking, as compared to anti-FcεRIα autoantibodies
    Izaki, S.
    Toyoshima, S.
    Endo, T.
    Hayama, K.
    Okayama, Y.
    Terui, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S217 - S217
12345